ZBH
Zimmer Biomet Holdings, Inc.
NYSE · Healthcare · Medical - Devices · US
$98.07
−0.86%Year over year
Reported trailing growth
- Revenue
- +8.6%
- EBITDA
- -13.9%
- EBIT
- +6.2%
- EPS
- +0.2%
- Free cash flow
- +28.5%
- Operating cash flow
- +4.8%
Forward estimates
Based on analyst estimates
- Revenue
- +2.8%
- EBITDA
- +51.0%
- EPS
- +111.9%
Three-year CAGR
- Revenue
- +5.9%
- EBITDA
- +14.1%
- EBIT
- +25.1%
- Net income
- +45.0%
- EPS
- +47.9%
- Free cash flow
- +11.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026